ATHA – athira pharma, inc. (US:NASDAQ)
Stock Stats
News
Athira Pharma Reports Third Quarter 2025 Financial Results and Provides Business Update
Athira Pharma (NASDAQ:ATHA) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
Athira Pharma (NASDAQ:ATHA) was given a new $4.00 price target on by analysts at Mizuho.
Athira Pharma Announces Reverse Stock Split [Yahoo! Finance]
Athira Pharma Announces Reverse Stock Split
Form SCHEDULE 13G Athira Pharma, Inc. Filed by: Baselake Partners, LP
Form 10-Q Athira Pharma, Inc. For: Sep 30
Form 8-K Athira Pharma, Inc. For: Nov 06
Form SCHEDULE 13G/A Athira Pharma, Inc. Filed by: Oliveira Steven Michael
Form 8-K Athira Pharma, Inc. For: Oct 02
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.